Meta tags:
keywords=;
description=;

Headings (most frequently used words):

you, about, to, exit, abbott, website, investors, newsroom, responsibility, careers, press, releases, are, for, another, country, or, region, specific, do, wish, continue, and, this, subscribe, consumers, healthcare, professionals, partners, contact, site, map, policies, privacy, policy, terms, conditions,

Text of the page (most frequently used words):
the (50), and (41), abbott (40), cancer (13), exact (11), sciences (11), for (9), with (9), that (8), are (8), #healthcare (8), loading (7), statements (7), people (7), other (6), not (6), about (6), forward (6), looking (6), acquisition (6), our (6), diagnostics (6), overview (6), you (5), this (5), website (5), site (5), 2026 (5), more (5), screening (5), professionals (5), may (4), products (4), privacy (4), risks (4), events (4), transaction (4), benefits (4), leading (4), early (4), personalized (4), growing (4), press (4), responsibility (4), careers (4), faqs (4), result (3), also (3), all (3), company (3), policy (3), terms (3), uncertainties (3), sec (3), from (3), ability (3), completion (3), will (3), global (3), leader (3), pipeline (3), detection (3), test (3), fast (3), segments (3), share (3), content (3), releases (3), contact (3), consumers (3), subscribe (3), exit (2), please (2), have (2), requested (2), country (2), region (2), information (2), medical (2), devices (2), those (2), countries (2), specific (2), otherwise (2), product (2), owned (2), its (2), any (2), trade (2), made (2), except (2), identify (2), further (2), preferences (2), health (2), conditions (2), policies (2), 224 (2), 668 (2), factors (2), businesses (2), annual (2), report (2), form (2), year (2), ended (2), their (2), december (2), 2025 (2), among (2), such (2), expectations (2), synergies (2), expected (2), realized (2), life (2), serve (2), facebook (2), linkedin (2), adds (2), treatment (2), decisions (2), help (2), disease (2), has (2), treatments (2), market (2), care (2), growth (2), establishing (2), march (2), stock (2), executive (2), team (2), mar (2), completes (2), newsroom (2), investors (2), glance (2), heritage (2), who (2), search (2), jobs (2), conferences (2), culture (2), students (2), working (2), news (2), yes, wish, continue, aware, intended, residents, particular, noted, contain, pharmaceuticals, uses, approved, regions, optimized, your, screen, size, another, unless, specified, service, names, appearing, internet, trademarks, licensed, subsidiaries, affiliates, use, trademark, name, dress, without, prior, written, authorization, services, rights, reserved, read, legal, notice, details, submit, eventtype, pageurl, advertising, myabbott, consumer, data, media, scott, stoffel, 5201, financial, michael, comilla, 1872, source, should, carefully, consider, foregoing, affect, described, risk, section, each, respectively, respective, reports, filed, free, copies, these, documents, obtained, speak, only, date, they, readers, cautioned, put, undue, reliance, undertakes, obligation, does, intend, release, publicly, revisions, subsequent, developments, required, law, www, gov, communication, contains, things, involve, substantial, could, cause, actual, results, differ, materially, expressed, implied, include, others, following, successfully, integrate, operations, implement, plans, forecasts, respect, business, after, related, realize, anticipated, including, possibility, within, time, period, helps, live, fully, stages, portfolio, changing, technologies, spans, spectrum, nutritionals, branded, generic, medicines, 122, 000, colleagues, than, 160, connect, youtube, instagram, com, next, generation, designed, detect, even, earlier, optimize, enable, regular, monitoring, stay, healthy, better, manage, now, comprehensive, suite, differentiated, focused, supporting, includes, cologuard, noninvasive, colorectal, option, oncotype, which, informs, patients, stage, breast, oncodetect, tumor, informed, molecular, residual, mrd, recurrence, guide, follow, cancerguard, multi, blood, industry, offerings, positions, advance, preventative, predictive, while, expanding, presence, one, fastest, areas, incidence, continues, rise, new, vertical, already, high, single, digit, leadership, precision, oncology, billion, strategic, fit, pursuant, merger, agreement, upon, became, wholly, subsidiary, was, last, day, trading, shares, nasdaq, scale, track, record, operational, commercial, excellence, work, systems, around, world, expand, access, important, tools, said, chairman, chief, officer, legacy, deep, expertise, ready, transform, robert, ford, nyse, abt, today, announced, completed, enabling, millions, additional, prnewswire, ill, park, advances, mission, make, accessible, give, control, over, establishes, close, download, res, photos, twitter, back, map, partners, fund, sustainability, social, impact, experts, honors, contacts, governance, resources, info, financials,

Text of the page (random words):
abbott completes acquisition of exact sciences mar 23 2026 investors overview financials stock info resources news events governance newsroom news press releases press contacts honors experts executive team responsibility overview social impact sustainability abbott fund subscribe consumers consumers healthcare professionals healthcare professionals careers overview working with us professionals students our people and culture benefits faqs conferences events search jobs careers overview working with us professionals students our people and culture benefits faqs conferences events search jobs about abbott overview who we are our heritage abbott at a glance abbott faqs contact us responsibility subscribe about abbott overview who we are our heritage abbott at a glance abbott faqs contact us responsibility subscribe consumers healthcare professionals careers about abbott careers investors newsroom responsibility partners contact site map policies privacy policy terms conditions press releases back to press releases abbott completes acquisition of exact sciences share content to facebook share content to linkedin share content to twitter photos 1 mar 23 2026 download hi res close establishes abbott as a leader in fast growing cancer screening and diagnostics segments advances abbott s mission to make healthcare more accessible and give people more control over their health abbott park ill march 23 2026 prnewswire abbott nyse abt today announced it has completed the acquisition of exact sciences establishing abbott as a leader in fast growing cancer screening and diagnostics segments and enabling the company to serve millions of additional people abbott s global scale track record of operational and commercial excellence and work with healthcare systems around the world will expand access to important tools for early cancer detection and personalized treatments said robert b ford chairman and chief executive officer abbott with the legacy and deep expertise of the exact sciences team we re ready to transform cancer care pursuant to the terms of the merger agreement upon completion of the acquisition exact sciences became a wholly owned subsidiary of abbott as a result of the completion of the acquisition march 20 2026 was the last day of trading of exact sciences shares on the nasdaq stock market strategic fit the transaction positions abbott to advance diagnostics that are more preventative predictive and personalized while expanding the company s presence in one of the fastest growing areas of healthcare as global cancer incidence continues to rise it also adds a new growth vertical to abbott s already high single digit growth expectations establishing leadership in the fast growing 60 billion u s cancer screening and precision oncology diagnostics segments industry leading offerings and pipeline abbott now has a comprehensive suite of products and differentiated pipeline focused on the early detection of cancer and supporting personalized treatments this includes the cologuard test a market leading noninvasive colorectal cancer screening option oncotype dx which informs personalized treatment decisions for patients with early stage breast cancer oncodetect a tumor informed molecular residual disease mrd test to help identify cancer recurrence and guide follow up care and cancerguard a multi cancer early detection blood test abbott also adds a leading pipeline of next generation cancer screening and diagnostics designed to detect cancer even earlier optimize treatment decisions and enable regular monitoring to help people stay healthy and better manage the disease about abbott abbott is a global healthcare leader that helps people live more fully at all stages of life our portfolio of life changing technologies spans the spectrum of healthcare with leading businesses and products in diagnostics medical devices nutritionals and branded generic medicines our 122 000 colleagues serve people in more than 160 countries connect with us at abbott com and on linkedin facebook instagram x and youtube forward looking statements this communication contains forward looking statements about among other things the acquisition of exact sciences by abbott forward looking statements involve substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements such risks and uncertainties include among others the following the ability of abbott to successfully integrate exact sciences operations the ability of abbott to implement its plans forecasts and other expectations with respect to exact sciences business after the completion of the transaction and risks related to the ability of abbott to realize the anticipated synergies and benefits of the transaction including the possibility that the expected synergies and benefits from the transaction will not be realized or will not be realized within the expected time period you should carefully consider the foregoing factors and the other risks and uncertainties that affect the businesses of abbott and exact sciences described in the risk factors section in each of abbott s annual report on form 10 k for the year ended december 31 2025 and exact sciences annual report on form 10 k for the year ended december 31 2025 respectively and their respective other reports filed with the sec free copies of these documents may be obtained from the sec s website at www sec gov forward looking statements speak only as of the date they are made readers are cautioned not to put undue reliance on forward looking statements and abbott undertakes no obligation and does not intend to release publicly any revisions to forward looking statements as a result of subsequent events or developments or otherwise except as required by law source abbott for further information abbott media scott stoffel 224 668 5201 abbott financial michael comilla 224 668 1872 policies terms conditions privacy policy consumer health data privacy policy myabbott privacy preferences advertising preferences pageurl eventtype submit 2026 abbott all rights reserved please read the legal notice for further details unless otherwise specified all product and service names appearing in this internet site are trademarks owned by or licensed to abbott its subsidiaries or affiliates no use of any abbott trademark trade name or trade dress in this site may be made without the prior written authorization of abbott except to identify the product or services of the company you are about to exit for another abbott country or region specific website please be aware that the website you have requested is intended for the residents of a particular country or region as noted on that site as a result the site may contain information on pharmaceuticals medical devices and other products or uses of those products that are not approved in other countries or regions the website you have requested also may not be optimized for your specific screen size do you wish to continue and exit this website yes no loading loading loading loading loading loading loading